Immunovant Inc • IMVT

Capital at risk.

About Immunovant Inc
Ticker
info
IMVT
Trading on
info
NASDAQ
ISIN
info
US45258J1025
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Eric Venker M.D., Pharm.D.
Headquarters
info
320 West 37th Street, New York, NY, United States, 10018
Employees
info
362
Website
info
https://immunovant.com
Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Metrics
BasicAdvanced
Market cap
info
$2.58B
P/E ratio
info
-
EPS
info
-$2.84
Dividend Yield
info
0.00%
Beta
info
0.66
Forward P/E ratio
info
0
EBIDTA
info
$-471M
Ex dividend date
info
-
Price & volume
Market cap
info
$2.58B
Average daily volume
info
1.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
4.25
Earnings
EPS
info
-$2.84
EPS estimate (current quarter)
info
-$0.67
EPS estimate (next quarter)
info
-$0.70
EBITDA
info
$-471M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.66
52-week High
info
$34.47
52-week Low
info
$12.72
50-day moving average
info
$16.42
200-day moving average
info
$19.77
Short ratio
info
12.77
Short %
info
29.06%
Management effectiveness
ROE (TTM)
info
-77.58%
ROA (TTM)
info
-47.07%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
174M
Float
info
67M
Insiders %
info
57.08%
Institutions %
info
55.60%
Analyst Insights & forecasts
info

93% Buy

7% Hold

0% Sell

Based on information from 14 analysts.

Average price target

info
$39.46
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.74
-$0.60
-23.33%
Q3 • 24Missed
-$0.76
-$0.75
-1.02%
Q4 • 24Missed
-$0.64
-$0.71
10.11%
Q1 • 25Beat
-$0.71
-$0.70
-1.43%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0.2M
$-106M
-66,530.63%
Q1 • 25
$0M
$-121M
-∞%
Q2 • 25
-100.00%
13.31%
∞%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$776M
$68.8M
8.86%
Q1 • 25
$661M
$52.9M
8.00%
Q2 • 25
-14.79%
-23.08%
-9.73%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-111M
$-0.2M
$451M
$-111M
Q1 • 25
$-117M
$0M
$2.9M
$-117M
Q2 • 25
6.12%
-100.00%
-99.35%
5.93%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Immunovant Inc share?
Collapse

Immunovant Inc shares are currently traded for undefined per share.

How many shares does Immunovant Inc have?
Collapse

Immunovant Inc currently has 174M shares.

Does Immunovant Inc pay dividends?
Collapse

No, Immunovant Inc doesn't pay dividends.

What is Immunovant Inc 52 week high?
Collapse

Immunovant Inc 52 week high is $34.47.

What is Immunovant Inc 52 week low?
Collapse

Immunovant Inc 52 week low is $12.72.

What is the 200-day moving average of Immunovant Inc?
Collapse

Immunovant Inc 200-day moving average is $19.77.

Who is Immunovant Inc CEO?
Collapse

The CEO of Immunovant Inc is Dr. Eric Venker M.D., Pharm.D..

How many employees Immunovant Inc has?
Collapse

Immunovant Inc has 362 employees.

What is the market cap of Immunovant Inc?
Collapse

The market cap of Immunovant Inc is $2.58B.

What is the P/E of Immunovant Inc?
Collapse

The current P/E of Immunovant Inc is null.

What is the EPS of Immunovant Inc?
Collapse

The EPS of Immunovant Inc is -$2.84.

What is the PEG Ratio of Immunovant Inc?
Collapse

The PEG Ratio of Immunovant Inc is null.

What do analysts say about Immunovant Inc?
Collapse

According to the analysts Immunovant Inc is considered a buy.